|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8960 EUR | -0.11% |
|
-0.44% | -22.09% |
| 07-17 | Oriola Oyj, Q2 2026 Earnings Call, Jul 17, 2026 | |
| 07-17 | Tranche Update on Oriola Oyj's Equity Buyback Plan announced on May 8, 2026. | CI |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Operating Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Product Distribution | ||||||||||
Services | - | - | - | 1.36B | 1.53B | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | -2.6M | -2.9M | |||||
EBITDA | - | - | - | - | 32.6M | |||||
D&A | - | - | - | 8.6M | 14.5M | |||||
Operating Income | - | - | - | 19M | 13.8M | |||||
Products | - | - | - | 316M | 375M | |||||
CAPEX | - | - | - | -200K | - | |||||
EBITDA | - | - | - | - | 10.3M | |||||
D&A | - | - | - | 3M | 3.1M | |||||
Operating Income | - | - | - | 9.5M | 6.9M | |||||
Wholesale - Drugs | - | 1.52B | 1.5B | - | - | |||||
Total Assets | - | 961M | 935M | - | - | |||||
Interest Expense | - | -2.2M | -5.3M | - | - | |||||
Income Tax Expense | - | 2.1M | 3.1M | - | - | |||||
CAPEX | - | -8.5M | -3.6M | - | - | |||||
EBT | - | 6.9M | -17.6M | - | - | |||||
D&A | - | 15.3M | 13.8M | - | - | |||||
Net Income | - | -2.4M | -20.7M | - | - | |||||
Pharma | 996M | - | - | - | - | |||||
Total Assets | 378M | - | - | - | - | |||||
CAPEX | -5.3M | - | - | - | - | |||||
D&A | 9.9M | - | - | - | - | |||||
Operating Income | 12.4M | - | - | - | - | |||||
Group Items | -438M | - | - | - | - | |||||
Total Assets | 168M | - | - | - | - | |||||
CAPEX | -200K | - | - | -100K | -200K | |||||
EBITDA | - | - | - | - | -7.9M | |||||
D&A | 400K | - | - | 2M | 200K | |||||
Operating Income | -8.8M | - | - | -6.8M | -18.2M | |||||
Invoicing between Segments | - | - | - | -600K | -300K | |||||
Healthcare Referral Services | ||||||||||
Healthcare | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
Drug Stores and Pharmacies | ||||||||||
Retail | 507M | - | - | - | - | |||||
Total Assets | 120M | - | - | - | - | |||||
CAPEX | -3.8M | - | - | - | - | |||||
D&A | 6.3M | - | - | - | - | |||||
Operating Income | 11.3M | - | - | - | - | |||||
Discontinued Operations | 818M | - | - | - | - | |||||
Total Assets | 427M | - | - | - | - | |||||
CAPEX | -13.5M | - | - | - | - | |||||
D&A | 28.3M | - | - | - | - | |||||
Operating Income | 11.4M | - | - | - | - |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Sweden | 1.33B | 894M | 837M | 1.09B | 1.21B | |||||
Total Assets | 745M | 81.5M | 55.1M | 29.2M | 3.7M | |||||
CAPEX | -19.3M | -1.4M | -800K | -1M | -1.8M | |||||
Finland | 431M | 508M | 536M | 550M | 565M | |||||
Total Assets | 348M | 332M | 290M | 284M | 282M | |||||
CAPEX | -3.5M | -2M | -2.7M | -1.8M | -1.3M | |||||
Other Countries | 120M | 113M | 121M | 36.2M | 126M | |||||
Total Assets | - | - | - | - | 400K | |||||
Baltic Countries | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - |
- Stock Market
- Stocks
- ORIOLA Stock
- Financials Oriola Oyj
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
